AI
Also, Kakao Healthcare is extending access to its AI to a public diabetes screening programme in South Korea.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.
HIMSS24
Jorie AI CEO Sal Lo discusses his company's product that helps reduce administrative workload and enables healthcare organizations to speed up eligibility verification and claims processing.
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
HIMSS24
Dr. Jeffrey Chen, clinical advisor at No Barrier AI, believes the company's AI medical interpreter app could improve outcomes for low-English-proficiency patients, prevent clinician burnout and reduce operational costs.
HIMSS24
Eric Robertson, chief technology strategist and growth officer at Jeeva Care, talks about how the company's AI companion helps patients track health goals and stick to their care program after a hospital stay.
Also, insurtech company Huize from China is expanding to Southeast Asia.
HIMSS24
Dr. Colin Banas, CMO at DrFirst, discusses the company's medication adherence product. It uses AI to send texts that educate patients about medications and provides coupons and co-pay-assistance program information, if cost is an issue.